The store will not work correctly when cookies are disabled.
4-(3-(2-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
ID: ALA3970855
PubChem CID: 18385866
Max Phase: Preclinical
Molecular Formula: C18H16FNO4S
Molecular Weight: 361.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2ccccc2F)C1=O
Standard InChI: InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(13-5-3-4-6-14(13)19)16(24-18)11-7-9-12(10-8-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)
Standard InChI Key: BTUAYXMLISLDMZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
25.6484 -8.7788 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4357 -9.5795 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.2354 -9.3634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1965 -14.2296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7877 -13.5164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3746 -14.2270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1229 -13.0321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4602 -13.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2043 -12.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3794 -12.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2449 -13.2901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8954 -11.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2322 -10.8306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7469 -10.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9249 -10.2501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5905 -11.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0777 -11.6738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6850 -11.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5074 -11.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9913 -10.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6540 -10.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8280 -10.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3478 -10.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6171 -9.6712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8439 -12.4172 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
6 5 1 0
7 5 1 0
5 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 2 1 0
2 24 1 0
19 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 361.39 | Molecular Weight (Monoisotopic): 361.0784 | AlogP: 2.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 86.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.08 | CX Basic pKa: ┄ | CX LogP: 2.94 | CX LogD: 2.94 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.91 | Np Likeness Score: -0.39 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |